All companies › ABEO

ABEO · ABEONA THERAPEUTICS INC.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells4
Research cases0
Last filing2026-09-29

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-29 — Vasanthavada Madhav · sold 4,902 @ $5.16 2026-09-29 — O'Malley Brendan M. · sold 6,727 @ $5.16 2026-09-29 — Vazzano Joseph Walter · sold 9,191 @ $5.16 2026-09-29 — Seshadri Vishwas · sold 19,608 @ $5.16
2026-09-292026-09-29

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Vasanthavada Madhav Chief Commercial Officer
O'Malley Brendan M. SVP, Chief Legal Officer
Vazzano Joseph Walter Chief Financial Officer
Seshadri Vishwas Chief Executive Officer, Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $ABEO is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-29', 'insider_name': 'Vasanthavada Madhav', 'insider_title': 'Chief Commercial Officer', 'transaction_type': 'Open-market sell', 'shares': 4902.0, 'price': 5.16, 'value': 25294.32, 'is_buy': False}, {'transaction_date': '2026-09-29', 'insider_name': "O'Malley Brendan M.", 'insider_title': 'SVP, Chief Legal Officer', 'transaction_type': 'Open-market sell', 'shares': 6727.0, 'price': 5.16, 'value': 34711.32, 'is_buy': False}, {'transaction_date': '2026-09-29', 'insider_name': 'Vazzano Joseph Walter', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 9191.0, 'price': 5.16, 'value': 47425.56, 'is_buy': False}, {'transaction_date': '2026-09-29', 'insider_name': 'Seshadri Vishwas', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 19608.0, 'price': 5.16, 'value': 101177.28, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for ABEO today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.